Drug intelligence / Profile preview

myo-inositol + berberine hcl + alpha lipoic acid + diindolylmethane + d-chiro-inositol

Development stage
Preclinical
Modality
Small Molecules
Administration
Oral
01

Overview

This is a **combination dietary supplement** containing five ingredients: - **myo-inositol**: a carbocyclic sugar that acts as a cellular messenger and plays a key role in insulin signaling and glucose metabolism. - **berberine hcl**: an isoquinoline alkaloid derived from plants (notably Berberis species) with evidence of insulin-sensitizing, hypoglycemic, and metabolic modulation properties. - **alpha lipoic acid**: a cofactor for mitochondrial enzymes with antioxidant activity; enhances insulin sensitivity and supports energy metabolism. - **diindolylmethane**: a compound formed from the digestion of indole-3-carbinol (cruciferous vegetables), modulating estrogen metabolism. - **d-chiro-inositol**: another inositol isomer with effects on insulin signaling, particularly beneficial in insulin resistance and polycystic ovary syndrome (PCOS). The combination is designed to support **metabolic health, insulin sensitivity, hormonal balance, and glucose homeostasis**, especially in metabolic syndrome, PCOS, and insulin resistance. There is evidence for the benefits of smaller subsets (notably myo-inositol plus d-chiro-inositol, with or without alpha lipoic acid; berberine individually) for these indications[1][2][3][4][5]. The use of all five ingredients simultaneously is seen in certain supplement products, but robust clinical data for this exact combination are not published.

02

Targets

AMPK (Adenosine monophosphate–activated protein kinase)

Beyond the preview

Go deeper on myo-inositol + berberine hcl + alpha lipoic acid + diindolylmethane + d-chiro-inositol.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on myo-inositol + berberine hcl + alpha lipoic acid + diindolylmethane + d-chiro-inositol.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call